Insider Transactions in Q3 2025 at Vor Biopharma Inc. (VOR)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 10
2025
|
Reprogrammed Interchange LLC |
SELL
Open market or private sale
|
Direct |
350,000
-1.01%
|
$350,000
$1.82 P/Share
|
|
Sep 09
2025
|
Reprogrammed Interchange LLC |
SELL
Open market or private sale
|
Direct |
449,226
-1.28%
|
$898,452
$2.0 P/Share
|
|
Sep 08
2025
|
Reprogrammed Interchange LLC |
SELL
Open market or private sale
|
Direct |
464,421
-1.31%
|
$464,421
$1.99 P/Share
|
|
Sep 05
2025
|
Reprogrammed Interchange LLC |
SELL
Open market or private sale
|
Direct |
400,000
-1.11%
|
$400,000
$1.97 P/Share
|
|
Sep 04
2025
|
Reprogrammed Interchange LLC |
SELL
Open market or private sale
|
Direct |
453,016
-1.25%
|
$453,016
$1.93 P/Share
|
|
Sep 03
2025
|
Reprogrammed Interchange LLC |
SELL
Open market or private sale
|
Direct |
554,612
-1.5%
|
$1,109,224
$2.0 P/Share
|
|
Aug 28
2025
|
Reprogrammed Interchange LLC |
SELL
Open market or private sale
|
Direct |
806,351
-2.14%
|
$1,612,702
$2.01 P/Share
|
|
Aug 27
2025
|
Reprogrammed Interchange LLC |
SELL
Open market or private sale
|
Direct |
611,647
-1.6%
|
$1,223,294
$2.01 P/Share
|
|
Aug 26
2025
|
Reprogrammed Interchange LLC |
SELL
Open market or private sale
|
Direct |
284,190
-0.74%
|
$568,380
$2.08 P/Share
|
|
Aug 25
2025
|
Reprogrammed Interchange LLC |
SELL
Open market or private sale
|
Direct |
387,346
-0.99%
|
$774,692
$2.12 P/Share
|
|
Jul 17
2025
|
Qing Che Zuraw Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
937,080
+50.0%
|
-
|
|
Jul 09
2025
|
Sandesh Mahatme CFO |
BUY
Grant, award, or other acquisition
|
Direct |
13,882,750
+50.0%
|
-
|